CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fleury SA Company Snapshot
Fleury SA operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other pharmaceutical manufacturers in Latin America: Genomma Lab Internacional Sab De Cv of MEXICO (2020 sales of 13.87 billion Mexican Pesos [US$688.65 million] of which 100% was PC), Instituto Hermes Pardini SA (1.49 billion Brazilian Reals [US$280.56 million] of which 100% was auxiliary diagnostic support services), and Hypera SA (4.09 billion Brazilian Reals [US$767.85 million] ).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Fleury SA totalled 932.07 million Brazilian Reals. This is an increase of 104.9% from the 454.94 million Brazilian Reals in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at Fleury SA in the previous 35 quarters. During the first two quarters of 2021, sales totalled 1.83 billion Brazilian Reals, which is 56.2% higher than through the first two quarters of 2020. There appears to be at least some degree of seasonality in the sales at Fleury SA: during 8 of the previous 9 years, sales were highest during the third quarter. The exception to this was during 2020, when the fourth quarter was the best quarter, accounting for 31% of sales (during that same year, the third quarter accounted for 29% of sales). During the year ended December of 2020, sales at Fleury SA were 2.97 billion Brazilian Reals (US$558.04 million). This is an increase of 2.3% versus 2019, when the company's sales were 2.91 billion Brazilian Reals. This was the fifth consecutive year of sales increases at Fleury SA (and since 2015, sales have increased a total of 57%). Sales of Integrated Medicine saw an increase that was more than double the company's growth rate: sales were up 15.3% in 2020, from 467.62 million Brazilian Reals to 538.93 million Brazilian Reals. Not all segments of Fleury SA experienced an increase in sales in 2020: sales of Diagnostic Medicine fell 0.2% to 2.43 billion Brazilian Reals.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fleury SA
  Stock Performance Chart for Fleury SA
 
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 24.02
(Figures in Brazilian Reals)
1 Week 1.7%   13 Weeks -0.7%  
4 Weeks -8.9%   52 Weeks -18.1%  
 
Fleury SA Key Data:
  Ticker: FLRY3 Country: Brazil
  Exchanges: SOP Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2020 Sales 2,971,616,000
(Year Ending Jan 2021).
Employees: 11,200
  Currency: Brazilian Reals Market Cap: 7,599,708,697
  Fiscal Yr Ends: December Shares Outstanding: 316,390,870
  Share Type: Ordinary Closely Held Shares: 142,600,342
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.